BioCentury
ARTICLE | Financial News

Micromet raises $40 million

October 4, 2008 12:43 AM UTC

Cancer, inflammation and autoimmune company Micromet (NASDAQ:MITI) completed its previously announced $40 million private placement of 9.4 million units at $4.25 per unit. Investors included Index Ventures; Abingworth; DAFNA Capital Management; and Merlin Nexus, as well as members of Micromet's board (See BioCentury Extra, Tuesday, Sep. 30, 2008). ...